WallStreetZenWallStreetZen

NASDAQ: ADIL
Adial Pharmaceuticals Inc Stock Ownership - Who owns Adial Pharmaceuticals?

Insider buying vs selling

Have Adial Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Cary J. ClaiborneChief Executive Officer2022-09-2075,000$0.42
$31.50kBuy
Cary J. ClaiborneChief Executive Officer2022-09-1925,000$0.43
$10.73kBuy

1 of 1

ADIL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADIL insiders and whales buy or sell their stock.

ADIL Shareholders

What type of owners hold Adial Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Cary J. Claiborne5.33%1,520,000$422.56kInsider
William B. Stilley Iii4.89%1,393,920$387.51kInsider
Manchester Capital Management LLC4.22%1,202,452$334.28kInstitution
Bankole A. Johnson3.06%872,720$242.62kInsider
James W. Newman Jr.1.54%438,742$121.97kInsider
Joseph Truluck0.93%265,139$73.71kInsider
Blackrock Inc0.79%225,855$62.79kInstitution
Susquehanna International Group LLP0.78%222,283$61.79kInstitution
Vanguard Group Inc0.71%203,358$56.53kInstitution
Kevin Schuyler0.52%147,242$40.93kInsider

1 of 3

ADIL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADIL8.63%16.68%Net Buying
CYCC20.04%59.16%
PYPD1.50%0.00%
PTIX2.20%3.49%
AGLE63.19%16.13%Net Buying

Adial Pharmaceuticals Stock Ownership FAQ

Who owns Adial Pharmaceuticals?

Adial Pharmaceuticals (NASDAQ: ADIL) is owned by 8.63% institutional shareholders, 16.68% Adial Pharmaceuticals insiders, and 74.69% retail investors. Cary J. Claiborne is the largest individual Adial Pharmaceuticals shareholder, owning 1.52M shares representing 5.33% of the company. Cary J. Claiborne's Adial Pharmaceuticals shares are currently valued at $440.80k.

If you're new to stock investing, here's how to buy Adial Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.